8-(4-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glycyl)piperazin-1-yl)piperidin-1-yl)-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[hicarbazole-3-carbonitrile

ID: ALA4865374

PubChem CID: 141762676

Max Phase: Preclinical

Molecular Formula: C45H46N8O6

Molecular Weight: 794.91

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1cc2c(cc1N1CCC(N3CCN(C(=O)CNc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O

Standard InChI:  InChI=1S/C45H46N8O6/c1-4-26-21-30-31(45(2,3)41-39(40(30)56)28-9-8-25(23-46)20-33(28)48-41)22-35(26)51-14-12-27(13-15-51)50-16-18-52(19-17-50)37(55)24-47-32-7-5-6-29-38(32)44(59)53(43(29)58)34-10-11-36(54)49-42(34)57/h5-9,20-22,27,34,47-48H,4,10-19,24H2,1-3H3,(H,49,54,57)

Standard InChI Key:  VYAVALFZAUHAMN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 59 67  0  0  0  0  0  0  0  0999 V2000
   29.6376  -21.2800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2332  -20.5742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8242  -21.2774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5312  -18.3416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0660  -19.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4179  -19.7544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3439  -18.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6983  -19.1394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2360  -19.8205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7409  -20.4707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.4889  -19.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5139  -20.1894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1820  -18.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9046  -19.3200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9336  -20.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6592  -20.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3563  -20.0899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3232  -19.2644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5972  -18.8837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0760  -20.4722    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1052  -21.2898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8240  -21.6712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5181  -21.2392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4888  -20.4216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7654  -20.0359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2387  -21.6263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.2649  -22.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9822  -22.8280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6779  -22.3987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6517  -21.5810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9298  -21.1926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0138  -18.8275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7375  -19.2072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1535  -18.1200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.2480  -18.9505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4334  -18.8857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.3978  -22.7855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4228  -23.6023    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.0927  -22.3554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8126  -22.7421    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.5074  -22.3120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2266  -22.7019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9210  -22.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8964  -21.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4801  -21.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1697  -21.0656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9697  -20.2754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1564  -20.2215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.8539  -20.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7228  -19.5311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1060  -18.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6740  -18.1188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8569  -18.1461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4737  -18.8690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9076  -19.5645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4928  -19.6476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.0617  -21.1789    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.9227  -18.7787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.4240  -17.4530    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 12  1  0
 11  8  1  0
 11 12  2  0
 12  2  1  0
  2 15  1  0
 14 13  1  0
 13 11  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 17 20  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 23 26  1  0
 18 32  1  0
 32 33  1  0
 13 34  2  0
 35 36  3  0
  5 35  1  0
 29 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 46  1  0
 45 41  1  0
 45 46  2  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 45  1  0
 50 51  1  0
 50 55  1  0
 51 52  1  0
 52 53  1  0
 53 54  1  0
 54 55  1  0
 48 50  1  0
 47 56  2  0
 49 57  2  0
 51 58  2  0
 53 59  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4865374

    ---

Associated Targets(Human)

SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin VHL/ALK (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H3122 (436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin Cereblon/EML4/ALK (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin Cereblon/NPM/ALK (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STAT3 Tchem Signal transducer and activator of transcription 3 (3313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 794.91Molecular Weight (Monoisotopic): 794.3540AlogP: 4.10#Rotatable Bonds: 7
Polar Surface Area: 179.02Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.48CX Basic pKa: 6.89CX LogP: 4.02CX LogD: 3.90
Aromatic Rings: 4Heavy Atoms: 59QED Weighted: 0.23Np Likeness Score: -0.47

References

1. Ren C, Sun N, Kong Y, Qu X, Liu H, Zhong H, Song X, Yang X, Jiang B..  (2021)  Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib.,  217  [PMID:33751979] [10.1016/j.ejmech.2021.113335]
2. Xie S, Sun Y, Liu Y, Li X, Li X, Zhong W, Zhan F, Zhu J, Yao H, Yang DH, Chen ZS, Xu J, Xu S..  (2021)  Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK).,  64  (13.0): [PMID:34176264] [10.1021/acs.jmedchem.1c00270]

Source